Quantcast
Last updated on April 23, 2014 at 10:35 EDT

Latest Interventional cardiology Stories

2013-11-12 23:29:31

ResearchMoz.us includes new market research report "China Interventional Cardiovascular Device Industry Report, 2013 - 2015" to its huge collection of research reports. View Full Report with TOC at: http://www.researchmoz.us/china-interventional-cardiovascular-device-industry-report-2013-2015-report.html. Albany, NY (PRWEB) November 12, 2013 ResearchMoz.us include new market research report "China Interventional Cardiovascular Device Industry Report, 2013 - 2015 " to...

2013-11-08 16:24:49

FRAMINGHAM, Mass., Nov. 8, 2013 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Canaccord Genuity Medical Technology & Diagnostics Forum at 1:30 p.m. ET on Thursday, November 14, 2013. The one-day conference is being held at the Westin Grand...

2013-11-06 08:30:11

German and UK Markets Hold Most Growth Opportunities For Competitors, According to Millennium Research Group TORONTO, Nov. 6, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the maturing European interventional cardiology (IC) device market will be supported by the uptake of complex procedures as well as adoption of innovative premium-priced products. Although percutaneous coronary interventions (PCIs)...

2013-11-05 16:27:53

FRAMINGHAM, Mass., Nov. 5, 2013 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Credit Suisse Healthcare Conference on Tuesday, November 12, 2013 at 10:30 a.m. MST. The conference will be held November 11-14 at the Phoenician Hotel in Scottsdale,...

2013-11-05 08:35:29

PLEASANTON, Calif., Nov. 5, 2013 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in two upcoming investor conferences. On Wednesday, November 13, the company will participate in the Credit Suisse 2013 Healthcare Conference. Taylor C. Harris, Vice President and Chief Financial Officer, will provide an update on the company,...

2013-11-01 11:28:50

'Hybrid procedure' combining minimally invasive corornary artery bypass surgery (CABG) with percutaneous coronary intervention is feasible and safe compared with traditional CABG A hybrid approach to treating coronary artery disease that involves a "hybrid procedure" combining a minimally invasive bypass surgery with percutaneous coronary intervention (PCI) was found to be feasible and safe in a clinical trial. This is the first randomized study of the technique. These findings were...

2013-10-31 10:26:48

Results of the Nordic-Baltic Bifurcation IV trial presented at TCT 2013 A new clinical trial shows that a two-stent technique for treatment of bifurcation lesions with a large stenotic side branch was not associated with significant improved outcomes compared to a provisional stenting approach. The findings from the Nordic-Baltic Bifurcation IV study were presented today at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular...

2013-10-30 15:34:04

New study compares 2 newer generation drug-eluting stents with biocompatible and biodegradable polymers A new study found that both drug-eluting stents (DES) with biocompatible polymers and DES with biodegradable polymers were associated with low major adverse coronary events, demonstrating the non-inferiority of the biocompatible polymer stents in patients undergoing percutaneous coronary intervention (PCI). The findings of the SORT-OUT VI trial were presented today at the 25th annual...

2013-10-30 08:32:41

Financial credit provided if second stent is required in a CorPath robotic-assisted angioplasty WALTHAM, Mass., Oct. 30, 2013 /PRNewswire/ -- Corindus Vascular Robotics, a leading provider of precision medical robotics, today announced the launch of its CorPath One Stent Program. The goal of the program is to raise awareness of the potential to decrease longitudinal geographic miss (LGM) caused by sub-optimal stent placement, as well as the patient safety and financial benefits...

2013-10-29 23:28:30

As the US population ages and obesity rises, cardiovascular device markets reach billions in market value. Vancouver, BC (PRWEB) October 29, 2013 iData Research, the leading global authority in medical device and pharmaceutical market research, has published a new report series for the U.S. Cardiology Device Markets. Cardiovascular disease is much more prevalent among patients over 55 years of age; therefore as the U.S. population ages, the incidence of cardiovascular disease will...


Latest Interventional cardiology Reference Libraries

Coronary Angiography
2013-07-29 11:05:01

A coronary angiography, also known as a coronary catheterization, is a procedure that gives both visual and tactical access to coronary circulation and blood filled chambers of the heart for both diagnostic and interventional purposes. It is one of many diagnostic tests used in cardiology. More specifically, coronary catheterization recognizes occlusion, stenosis, thrombosis or aneurismal enlargement of the walls of the coronary arteries; heart chamber size; heart muscle contraction...

More Articles (1 articles) »